{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:09:25Z","timestamp":1791662965018,"version":"4.3.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2017\/04138-8"],"award-info":[{"award-number":["#2017\/04138-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2017\/04138-8"],"award-info":[{"award-number":["#2017\/04138-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["# 465687\/2014-8"],"award-info":[{"award-number":["# 465687\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05683-w","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:22:42Z","timestamp":1751394162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antiviral and anti-inflammatory efficacy of nanoencapsulated brazilian green propolis against SARS-CoV-2"],"prefix":"10.1038","volume":"15","author":[{"given":"Iasmin Rosanne Silva","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Ara\u00fajo","family":"Justino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo Bragan\u00e7a","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vit\u00f3ria Oliveira","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Melquiades","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"de Freitas Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eurico","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo Kenupp","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscyla Daniely","family":"Marcato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5683_CR1","doi-asserted-by":"publisher","unstructured":"Tu, Y. F. et al. A review of sars-cov-2 and the ongoing clinical trials. International Journal of Molecular Sciences vol. 21 Preprint at (2020). https:\/\/doi.org\/10.3390\/ijms21072657","DOI":"10.3390\/ijms21072657"},{"key":"5683_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/978-1-61779-953-2_41","volume":"906","author":"M Wright","year":"2012","unstructured":"Wright, M. Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions. Methods Mol. Biol. 906, 511\u2013524 (2012).","journal-title":"Methods Mol. Biol."},{"key":"5683_CR3","unstructured":"WHO Coronavirus (COVID-19) Dashboard. (2023). https:\/\/covid19.who.int"},{"key":"5683_CR4","doi-asserted-by":"publisher","unstructured":"Huang, L. et al. Progress in the Research and Development of Anti-COVID-19 Drugs. Frontiers in Public Health vol. 8 Preprint at (2020). https:\/\/doi.org\/10.3389\/fpubh.2020.00365","DOI":"10.3389\/fpubh.2020.00365"},{"key":"5683_CR5","doi-asserted-by":"publisher","unstructured":"Montani, D. et al. Post-acute COVID-19 syndrome. European Respiratory Review vol. 31 Preprint at (2022). https:\/\/doi.org\/10.1183\/16000617.0185-2021","DOI":"10.1183\/16000617.0185-2021"},{"key":"5683_CR6","doi-asserted-by":"publisher","first-page":"e17812441092","DOI":"10.33448\/rsd-v12i4.41092","volume":"12","author":"NB Mani\u00e7oba","year":"2023","unstructured":"Mani\u00e7oba, N. B. et al. Post-acute COVID-19 syndrome and musculoskeletal manifestations: an overview. Res. Soc. Dev. 12, e17812441092 (2023).","journal-title":"Res. Soc. Dev."},{"key":"5683_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","volume":"588","author":"Z Ke","year":"2020","unstructured":"Ke, Z. et al. Structures and distributions of SARS-CoV-2 Spike proteins on intact virions. Nature 588, 498\u2013502 (2020).","journal-title":"Nature"},{"key":"5683_CR8","doi-asserted-by":"publisher","first-page":"Preprintathttps","DOI":"10.1016\/j.virusres.2020.198141","volume":"288","author":"SK Samrat","year":"2020","unstructured":"Samrat, S. K., Tharappel, A. M., Li, Z. & Li, H. Prospect of SARS-CoV-2 Spike protein: potential role in vaccine and therapeutic development. Virus Res. 288, Preprintathttpsdoiorg101016jvirusres2020198141 (2020).","journal-title":"Virus Res."},{"key":"5683_CR9","doi-asserted-by":"crossref","unstructured":"Yamamoto, Y. et al. Direct Inhibition of SARS-CoV-2 Spike protein by peracetic acid. Int J. Mol. Sci 24, 1\u201315 (2023).","DOI":"10.3390\/ijms24010020"},{"key":"5683_CR10","doi-asserted-by":"crossref","unstructured":"Machado, C. S. et al. Comparative Study of Chemical Composition and Biological Activity of Yellow, Green, Brown, and Red Brazilian Propolis. Evidence-based Complementary and Alternative Medicine (2016). (2016).","DOI":"10.1155\/2016\/6057650"},{"key":"5683_CR11","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/ptr.6875","volume":"35","author":"FP Beserra","year":"2021","unstructured":"Beserra, F. P. et al. Artepillin C as an outstanding phenolic compound of Brazilian green propolis for disease treatment: A review on Pharmacological aspects. Phytother. Res. 35, 2274\u20132286 (2021).","journal-title":"Phytother. Res."},{"key":"5683_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jep.2018.08.006","volume":"226","author":"P Costa","year":"2018","unstructured":"Costa, P. et al. Artepillin C, drupanin, aromadendrin-4\u2032-O-methyl-ether and Kaempferide from Brazilian green propolis promote gastroprotective action by diversified mode of action. J. Ethnopharmacol. 226, 82\u201389 (2018).","journal-title":"J. Ethnopharmacol."},{"key":"5683_CR13","first-page":"3","volume":"14","author":"H Sobhani","year":"2015","unstructured":"Sobhani, H. et al. Formulation development and toxicity assessment of Triacetin mediated nanoemulsions as novel delivery systems for Rapamycin. Iran. J. Pharm. Res. 14, 3\u201321 (2015).","journal-title":"Iran. J. Pharm. Res."},{"key":"5683_CR14","doi-asserted-by":"crossref","unstructured":"Xu, X. et al. The chemical composition of Brazilian green propolis and its protective effects on mouse aortic endothelial cells against inflammatory injury. Molecules 25, 1\u201312 (2020).","DOI":"10.3390\/molecules25204612"},{"key":"5683_CR15","doi-asserted-by":"crossref","unstructured":"Tomazzoli, M. M. et al. Botanical source investigation and evaluation of the effect of seasonality on Brazilian propolis from apis mellifera L. Sci Agric 77, 1\u20138 (2020).","DOI":"10.1590\/1678-992x-2018-0258"},{"key":"5683_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/foods10081776","volume":"10","author":"N Yosri","year":"2021","unstructured":"Yosri, N. et al. Anti-Viral and Immunomodulatory properties of propolis: chemical diversity, Pharmacological properties, preclinical and clinical applications, and in Silico potential against SARS-CoV-2. Foods 10, 1\u201347 (2021).","journal-title":"Foods"},{"key":"5683_CR17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1080\/09603123.2022.2110576","volume":"33","author":"NP Silva-Beltr\u00e1n","year":"2022","unstructured":"Silva-Beltr\u00e1n, N. P. et al. In vitro antiviral effect of Mexican and Brazilian propolis and phenolic compounds against human coronavirus 229E. Int. J. Environ. Health Res. 33, 1591\u20131603 (2022).","journal-title":"Int. J. Environ. Health Res."},{"key":"5683_CR18","doi-asserted-by":"publisher","unstructured":"Ripari, N. et al. Propolis antiviral and immunomodulatory activity: A review and perspectives for COVID-19 treatment. Journal of Pharmacy and Pharmacology vol. 73 281\u2013299 Preprint at (2021). https:\/\/doi.org\/10.1093\/JPP\/RGAA067","DOI":"10.1093\/JPP\/RGAA067"},{"key":"5683_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6061\/clinics\/2021\/e2357","volume":"76","author":"AC Fiorini","year":"2021","unstructured":"Fiorini, A. C. et al. Antiviral activity of Brazilian green propolis extract against sars-cov-2 (Severe acute respiratory syndrome-coronavirus 2) infection: case report and review. Clinics 76, 1\u20134 (2021).","journal-title":"Clinics"},{"key":"5683_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/jpp\/rgad030","volume":"75","author":"IA Justino","year":"2023","unstructured":"Justino, I. A. et al. Brazilian red propolis extract free and encapsulated into polymeric nanoparticles against ovarian cancer: formulation, characterisation and biological assays in 2D and 3D models. J. Pharm. Pharmacol. 75, 806\u2013818 (2023).","journal-title":"J. Pharm. Pharmacol."},{"key":"5683_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-021-00639-z","volume":"19","author":"P Anvarifard","year":"2022","unstructured":"Anvarifard, P., Anbari, M., Ostadrahimi, A., Ardalan, M. & Ghoreishi, Z. A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review. Nutr. Metab. (Lond). 19, 1\u201323 (2022).","journal-title":"Nutr. Metab. (Lond)"},{"key":"5683_CR22","doi-asserted-by":"publisher","unstructured":"Patra, J. K. et al. Nano based drug delivery systems: Recent developments and future prospects. Journal of Nanobiotechnology vol. 16 Preprint at (2018). https:\/\/doi.org\/10.1186\/s12951-018-0392-8","DOI":"10.1186\/s12951-018-0392-8"},{"key":"5683_CR23","doi-asserted-by":"publisher","unstructured":"Chan, W. C. W. Nano Research for COVID-19. ACS Nano vol. 14 3719\u20133720 Preprint at (2020). https:\/\/doi.org\/10.1021\/acsnano.0c02540","DOI":"10.1021\/acsnano.0c02540"},{"key":"5683_CR24","doi-asserted-by":"publisher","first-page":"102227","DOI":"10.1016\/j.cis.2020.102227","volume":"283","author":"M Jalali-Jivan","year":"2020","unstructured":"Jalali-Jivan, M., Garavand, F. & Jafari, S. M. Microemulsions as nano-reactors for the solubilization, separation, purification and encapsulation of bioactive compounds. Adv. Colloid Interface Sci. 283, 102227 (2020).","journal-title":"Adv. Colloid Interface Sci."},{"key":"5683_CR25","doi-asserted-by":"publisher","first-page":"130376","DOI":"10.1016\/j.foodchem.2021.130376","volume":"364","author":"F Garavand","year":"2021","unstructured":"Garavand, F., Jalai-Jivan, M., Assadpour, E. & Jafari, S. M. Encapsulation of phenolic compounds within nano\/microemulsion systems: A review. Food Chem. 364, 130376 (2021).","journal-title":"Food Chem."},{"key":"5683_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/03639045.2016.1235186","volume":"43","author":"FH Xavier-Junior","year":"2017","unstructured":"Xavier-Junior, F. H., Vauthier, C., Morais, A. R. V., Alencar, E. N. & Egito, E. S. T. Microemulsion systems containing bioactive natural oils: an overview on the state of the Art. Drug Dev. Ind. Pharm. 43, 700\u2013714 (2017).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"5683_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ijbiomac.2014.01.041","volume":"65","author":"Y Fan","year":"2014","unstructured":"Fan, Y. et al. The design of propolis flavone microemulsion and its effect on enhancing the immunity and antioxidant activity in mice. Int. J. Biol. Macromol. 65, 200\u2013207 (2014).","journal-title":"Int. J. Biol. Macromol."},{"key":"5683_CR28","doi-asserted-by":"crossref","unstructured":"\u017dilius, M., Ramanauskiene, K., Ju\u0161kaite, V. & Briedis, V. Formulation of Propolis Phenolic Acids Containing Microemulsions and Their Biopharmaceutical Characterization. Evidence-based Complementary and Alternative Medicine (2016). (2016).","DOI":"10.1155\/2016\/8175265"},{"key":"5683_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/03639040600599806","volume":"32","author":"L Montenegro","year":"2006","unstructured":"Montenegro, L., Carbone, C., Condorelli, G., Drago, R. & Puglisi, G. Effect of oil phase lipophilicity on in vitro drug release from o\/w microemulsions with low surfactant content. Drug Dev. Ind. Pharm. 32, 539\u2013548 (2006).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"5683_CR30","doi-asserted-by":"crossref","unstructured":"Honary, S. & Zahir, F. Effect of zeta potential on the properties of Nano-Drug delivery Systems - A review (Part 2). Tropical J. Pharm. Research 12, 265\u2013273 (2013).","DOI":"10.4314\/tjpr.v12i2.19"},{"key":"5683_CR31","doi-asserted-by":"publisher","unstructured":"Monakhova, P. A., Shalaev, P. V. & Gorev, I. N. Rapid characterization of synthesized nanoparticles\u2019 liquid dispersions using nanoparticle tracking analysis. in 65 (2023). https:\/\/doi.org\/10.3390\/iocn2023-14528","DOI":"10.3390\/iocn2023-14528"},{"key":"5683_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1231464","volume":"2017","author":"LNM Ribeiro","year":"2017","unstructured":"Ribeiro, L. N. M. et al. Advances in hybrid Polymer-Based materials for sustained drug release. Int. J. Polym. Sci. 2017, 1\u201316 (2017).","journal-title":"Int. J. Polym. Sci."},{"key":"5683_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12247-022-09668-4","volume":"18","author":"L Lamoudi","year":"2023","unstructured":"Lamoudi, L., Akretche, S., Hadjsadok, A. & Daoud, K. Fusidic acid microemulsion based on a pseudoternary phase diagram: development, characterization, and evaluation. J. Pharm. Innov. 18, 621\u2013628 (2023).","journal-title":"J. Pharm. Innov."},{"key":"5683_CR34","first-page":"868","volume":"65","author":"A Hazem","year":"2017","unstructured":"Hazem, A. et al. The antiviral\/virucidal effects of alchoolic and aqueous extracts with propolis. Farmacia 65, 868\u2013876 (2017).","journal-title":"Farmacia"},{"key":"5683_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2020.110622","volume":"131","author":"AA Berretta","year":"2020","unstructured":"Berretta, A. A., Silveira, M. A. D., C\u00f3ndor Capcha, J. M. & De Jong, D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease. Biomed. Pharmacother. 131, 1\u201316 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"5683_CR36","doi-asserted-by":"publisher","first-page":"58628","DOI":"10.1007\/s11356-022-21652-6","volume":"29","author":"S Ghosh","year":"2022","unstructured":"Ghosh, S. et al. Propolis efficacy on SARS-COV viruses: a review on antimicrobial activities and molecular simulations. Environ. Sci. Pollut. Res. 29, 58628\u201358647 (2022).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"5683_CR37","doi-asserted-by":"crossref","unstructured":"Khayrani, A. C. et al. Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular Docking for COVID-19 drug discovery preliminary study. J King Saud Univ. Sci 33, 1\u20132 (2021).","DOI":"10.1016\/j.jksus.2020.101297"},{"key":"5683_CR38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/07853890.2022.2031274","volume":"54","author":"Q Fernandes","year":"2022","unstructured":"Fernandes, Q. et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann. Med. 54, 524\u2013540 (2022).","journal-title":"Ann. Med."},{"key":"5683_CR39","doi-asserted-by":"publisher","first-page":"101588","DOI":"10.1016\/j.bjid.2021.101588","volume":"25","author":"JC da Silva","year":"2021","unstructured":"da Silva, J. C., F\u00e9lix, V. B., Le\u00e3o, S. A. B. F., Trindade-Filho, E. M. & Scorza, F. A. New Brazilian variant of the SARS-CoV-2 (P1\/Gamma) of COVID-19 in Alagoas state. Brazilian J. Infect. Dis. 25, 101588 (2021).","journal-title":"Brazilian J. Infect. Dis."},{"key":"5683_CR40","first-page":"83","volume":"5","author":"S Alexandar","year":"2021","unstructured":"Alexandar, S., Ravisankar, M., Kumar, R. S. & Jakkan, K. A comprehensive review on Covid-19 Delta variant. Int. J. Pharmacol. Clin. Res. 5, 83\u201385 (2021).","journal-title":"Int. J. Pharmacol. Clin. Res."},{"key":"5683_CR41","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/jmv.27588","volume":"94","author":"Y Araf","year":"2022","unstructured":"Araf, Y. et al. Omicron variant of SARS-CoV\u20102: genomics, transmissibility, and responses to current COVID\u201019 vaccines. J. Med. Virol. 94, 1825\u20131832 (2022).","journal-title":"J. Med. Virol."},{"key":"5683_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280e8 (2020).","journal-title":"Cell"},{"key":"5683_CR43","doi-asserted-by":"publisher","first-page":"120028","DOI":"10.1016\/j.ijpharm.2020.120028","volume":"592","author":"H Refaat","year":"2021","unstructured":"Refaat, H., Mady, F. M., Sarhan, H. A., Rateb, H. S. & Alaaeldin, E. Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19. Int. J. Pharm. 592, 120028 (2021).","journal-title":"Int. J. Pharm."},{"key":"5683_CR44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.12659\/MSM.897282","volume":"22","author":"A Yildirim","year":"2016","unstructured":"Yildirim, A. et al. Antiviral activity of Hatay propolis against replication of herpes simplex virus type 1 and type 2. Med. Sci. Monit. 22, 422\u2013430 (2016).","journal-title":"Med. Sci. Monit."},{"key":"5683_CR45","first-page":"733","volume":"73","author":"K Labsk\u00e1","year":"2018","unstructured":"Labsk\u00e1, K., Plodkov\u00e1, H., Pumannov\u00e1, M. & Sensch, K. H. Antiviral activity of propolis special extract GH 2002 against varicella Zoster virus in vitro. Pharmazie 73, 733\u2013736 (2018).","journal-title":"Pharmazie"},{"key":"5683_CR46","doi-asserted-by":"publisher","first-page":"28510","DOI":"10.1007\/s11356-019-07458-z","volume":"27","author":"NP Silva-Beltr\u00e1n","year":"2020","unstructured":"Silva-Beltr\u00e1n, N. P., Balderrama-Carmona, A. P. & Umsza-Guez, M. A. Souza machado, B. A. Antiviral effects of Brazilian green and red propolis extracts on enterovirus surrogates. Environ. Sci. Pollut. Res. 27, 28510\u201328517 (2020).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"5683_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines7040073","volume":"7","author":"P Governa","year":"2019","unstructured":"Governa, P. et al. Beyond the biological effect of a chemically characterized Poplar propolis: antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells. Biomedicines 7, 1\u201310 (2019).","journal-title":"Biomedicines"},{"key":"5683_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jep.2005.05.045","volume":"102","author":"G Gekker","year":"2005","unstructured":"Gekker, G., Hu, S., Spivak, M., Lokensgard, J. R. & Peterson, P. K. Anti-HIV-1 activity of propolis in CD4\u2009+\u2009lymphocyte and microglial cell cultures. J. Ethnopharmacol. 102, 158\u2013163 (2005).","journal-title":"J. Ethnopharmacol."},{"key":"5683_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4314\/ajtcam.v12i4.16","volume":"12","author":"M de B\u00farquez","year":"2015","unstructured":"de B\u00farquez, M. Protective effect of a Mexican propolis on MDBK cells exposed to aujeszky\u2019s disease virus (pseudorabies virus). Afr. J. Tradit. Complement. Altern. Med. 12, 106\u2013111 (2015).","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"5683_CR50","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/ptr.5054","volume":"28","author":"H Maruta","year":"2014","unstructured":"Maruta, H. Herbal therapeutics that block the oncogenic kinase PAK1: A practical approach towards PAK1-dependent diseases and longevity. Phytother. Res. 28, 656\u2013672 (2014).","journal-title":"Phytother. Res."},{"key":"5683_CR51","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3109\/08923973.2012.657304","volume":"34","author":"Y Okamoto","year":"2012","unstructured":"Okamoto, Y., Tanaka, M., Fukui, T. & Masuzawa, T. Brazilian propolis inhibits the differentiation of Th17 cells by Inhibition of interleukin-6-induced phosphorylation of signal transducer and activator of transcription 3. Immunopharmacol. Immunotoxicol. 34, 803\u2013809 (2012).","journal-title":"Immunopharmacol. Immunotoxicol"},{"key":"5683_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/418508","volume":"2013","author":"JI Hori","year":"2013","unstructured":"Hori, J. I., Zamboni, D. S., Carr\u00e3o, D. B., Goldman, G. H. & Berretta, A. A. The Inhibition of inflammasome by Brazilian Propolis (EPP-AF). Evidence-Based Complement. Altern. Med. 2013, 1\u201311 (2013).","journal-title":"Evidence-Based Complement. Altern. Med."},{"key":"5683_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1872214808666140619115319","volume":"8","author":"S Figueiredo","year":"2014","unstructured":"Figueiredo, S. et al. Immunomodulatory properties of green Propolis. Recent. Pat. Endocr. Metab. Immune Drug Discov. 8, 85\u201394 (2014).","journal-title":"Recent. Pat. Endocr. Metab. Immune Drug Discov"},{"key":"5683_CR54","doi-asserted-by":"publisher","first-page":"100039","DOI":"10.1016\/j.medidd.2020.100039","volume":"6","author":"H Maruta","year":"2020","unstructured":"Maruta, H. & He, H. PAK1-blockers: potential therapeutics against COVID-19. Med. Drug Discov. 6, 100039 (2020).","journal-title":"Med. Drug Discov"},{"key":"5683_CR55","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jep.2006.10.023","volume":"110","author":"I Jasprica","year":"2007","unstructured":"Jasprica, I. et al. In vivo study of propolis supplementation effects on antioxidative status and red blood cells. J. Ethnopharmacol. 110, 548\u2013554 (2007).","journal-title":"J. Ethnopharmacol."},{"key":"5683_CR56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/00218839.2019.1695715","volume":"59","author":"MJ Kwon","year":"2020","unstructured":"Kwon, M. J., Shin, H. M., Perumalsamy, H., Wang, X. & Ahn, Y. J. Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds. J. Apic. Res. 59, 413\u2013425 (2020).","journal-title":"J. Apic. Res."},{"key":"5683_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1051\/apido:19920306","volume":"23","author":"M Amoros","year":"1992","unstructured":"Amoros, M., Sauvager, F., Girre, L. & Cormier, M. In vitro antiviral activity of propolis. Apidologie 23, 231\u2013240 (1992).","journal-title":"Apidologie"},{"key":"5683_CR58","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00228-020-02963-4","volume":"76","author":"G Ragia","year":"2020","unstructured":"Ragia, G. & Manolopoulos, V. G. Inhibition of SARS-CoV-2 entry through the ACE2\/TMPRSS2 pathway: a promising approach for Uncovering early COVID-19 drug therapies. Eur. J. Clin. Pharmacol. 76, 1623\u20131630 (2020).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"5683_CR59","doi-asserted-by":"crossref","unstructured":"Da, J. et al. Kaempferol promotes apoptosis while inhibiting cell proliferation via androgen-dependent pathway and suppressing vasculogenic mimicry and invasion in prostate cancer. Analytical Cellular Pathology (2019). (2019).","DOI":"10.1155\/2019\/1907698"},{"key":"5683_CR60","doi-asserted-by":"publisher","DOI":"10.14293\/S2199-1006.1.SOR-.PP5BWN4.v1","author":"G Halil Ibrahim G\u00fcler","year":"2020","unstructured":"Halil Ibrahim G\u00fcler, G., Tatar, O., Yildiz, A. O. & Belduz, S. K. An investigation of ethanolic propolis extracts: their potential inhibitor properties against ACE-II receptors for COVID-19 treatment by molecular Docking study Karadeniz technical university, faculty of science, department of molecular biology and gen. So https:\/\/doi.org\/10.14293\/S2199-1006.1.SOR-.PP5BWN4.v1 (2020).","journal-title":"So"},{"key":"5683_CR61","doi-asserted-by":"publisher","first-page":"100162","DOI":"10.1016\/j.medidd.2023.100162","volume":"20","author":"KS Yadav","year":"2023","unstructured":"Yadav, K. S. et al. Microemulsions for enhancing drug delivery of hydrophilic drugs: exploring various routes of administration. Med. Drug Discov. 20, 100162 (2023).","journal-title":"Med. Drug Discov"},{"key":"5683_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/antiox9010075","volume":"9","author":"SM Os\u00e9s","year":"2020","unstructured":"Os\u00e9s, S. M. et al. Phenolic profile, antioxidant capacities and enzymatic inhibitory activities of Propolis from different geographical areas: needs for analytical harmonization. Antioxidants 9, 75 (2020).","journal-title":"Antioxidants"},{"key":"5683_CR63","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706\u2013714 (2022).","journal-title":"Nature"},{"key":"5683_CR64","doi-asserted-by":"publisher","first-page":"e0255622","DOI":"10.1371\/journal.pone.0255622","volume":"16","author":"C Pommerenke","year":"2021","unstructured":"Pommerenke, C. et al. Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies. PLoS One. 16, e0255622 (2021).","journal-title":"PLoS One"},{"key":"5683_CR65","first-page":"1","volume":"0","author":"V Kumar","year":"2020","unstructured":"Kumar, V., Dhanjal, J. K., Kaul, S. C., Wadhwa, R. & Sundar, D. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J. Biomol. Struct. Dyn. 0, 1\u201313 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"5683_CR66","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2174\/0115680266280720231221100004","volume":"24","author":"V Kumar","year":"2024","unstructured":"Kumar, V. et al. Anti-COVID-19 potential of Withaferin-A and caffeic acid phenethyl ester. Curr. Top. Med. Chem. 24, 830\u2013842 (2024).","journal-title":"Curr. Top. Med. Chem."},{"key":"5683_CR67","doi-asserted-by":"crossref","unstructured":"Ali, A. M. & Kunugi, H. Propolis, bee honey, and their components protect against coronavirus disease 2019 (Covid-19): A review of in silico, in vitro, and clinical studies. Molecules 26, 1\u201321 (2021).","DOI":"10.3390\/molecules26051232"},{"key":"5683_CR68","doi-asserted-by":"publisher","first-page":"e48072","DOI":"10.1371\/journal.pone.0048072","volume":"7","author":"T Hata","year":"2012","unstructured":"Hata, T. et al. Artepillin C, a major ingredient of Brazilian propolis, induces a pungent taste by activating TRPA1 channels. PLoS One. 7, e48072 (2012).","journal-title":"PLoS One"},{"key":"5683_CR69","doi-asserted-by":"crossref","unstructured":"Righi, A. A., Negri, G. & Salatino, A. Comparative Chemistry of Propolis from Eight Brazilian Localities. Evidence-Based Complementary and Alternative Medicine 1\u201314 (2013). (2013).","DOI":"10.1155\/2013\/267878"},{"key":"5683_CR70","doi-asserted-by":"publisher","unstructured":"Shahinozzaman, M. et al. A comprehensive review of its chemistry, bioavailability, and pharmacological properties. Fitoterapia vol. 147 Preprint at (2020). https:\/\/doi.org\/10.1016\/j.fitote.2020.104775","DOI":"10.1016\/j.fitote.2020.104775"},{"key":"5683_CR71","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.drudis.2020.03.008","volume":"25","author":"H Maruta","year":"2020","unstructured":"Maruta, H. & Kittaka, A. PAK1-blockers: potential therapeutics against COVID-19. Drug Discov Today. 25, 959\u2013964 (2020).","journal-title":"Drug Discov Today"},{"key":"5683_CR72","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1128\/JVI.02560-09","volume":"84","author":"IY Chen","year":"2010","unstructured":"Chen, I. Y. et al. Upregulation of the chemokine (C-C Motif) ligand 2 via a severe acute respiratory syndrome coronavirus Spike-ACE2 signaling pathway. J. Virol. 84, 7703\u20137712 (2010).","journal-title":"J. Virol."},{"key":"5683_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/095632020801900102","volume":"19","author":"T Shimizu","year":"2008","unstructured":"Shimizu, T. et al. Anti-Influenza virus activity of Propolis in vitro and its efficacy against influenza infection in mice. Antivir Chem. Chemother. 19, 7\u201313 (2008).","journal-title":"Antivir Chem. Chemother."},{"key":"5683_CR74","doi-asserted-by":"crossref","unstructured":"Ferreira, J. C. et al. Baccharin and p-coumaric acid from green propolis mitigate inflammation by modulating the production of cytokines and eicosanoids. J Ethnopharmacol 278, 1\u20138 (2021).","DOI":"10.1016\/j.jep.2021.114255"},{"key":"5683_CR75","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s10787-025-01647-8","volume":"33","author":"RA El-Shiekh","year":"2025","unstructured":"El-Shiekh, R. A., Radi, M. H. & Abdel-Sattar, E. Unveiling the therapeutic potential of aromadendrin (AMD): a promising anti-inflammatory agent in the prevention of chronic diseases. Inflammopharmacology 33, 1209\u20131220 (2025).","journal-title":"Inflammopharmacology"},{"key":"5683_CR76","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Identifying Active Compounds and Mechanism of Camellia nitidissima Chi on Anti-Colon Cancer by Network Pharmacology and Experimental Validation. Evidence-based Complementary and Alternative Medicine (2021). (2021).","DOI":"10.1155\/2021\/7169211"},{"key":"5683_CR77","doi-asserted-by":"crossref","unstructured":"Aijaz, M. et al. Chemical, biological, and Pharmacological prospects of caffeic acid. Biointerface Res. Appl. Chem 13, 1\u201326 (2023).","DOI":"10.33263\/BRIAC134.324"},{"key":"5683_CR78","doi-asserted-by":"publisher","first-page":"120","DOI":"10.35652\/IGJPS.2021.112007","volume":"11","author":"S Sharma","year":"2021","unstructured":"Sharma, S., Khatkar, A. & Kakkar, S. A. Review: p-Coumaric acid, A medicinally important phenolic acid moiety. Indo Global J. Pharm. Sci. 11, 120\u2013129 (2021).","journal-title":"Indo Global J. Pharm. Sci."},{"key":"5683_CR79","doi-asserted-by":"crossref","unstructured":"Schepetkin, I. A. et al. Neutrophil Immunomodulatory Activity of Nerolidol, a Major Component of Essential Oils from Populus balsamifera Buds and Propolis. Plants 11, (2022).","DOI":"10.3390\/plants11233399"},{"key":"5683_CR80","doi-asserted-by":"crossref","unstructured":"de Costa, I. F. et al. J. B. Anti-mycobacterial and immunomodulatory activity of n-hexane fraction and spathulenol from Ocotea notata leaves. Rodrigu\u00e9sia 72, (2021).","DOI":"10.1590\/2175-7860202172041"},{"key":"5683_CR81","first-page":"987","volume":"5","author":"MA Hassan","year":"2023","unstructured":"Hassan, M. A. et al. A comparative study of selected immunological markers on children with normal tonsils, simple hypertrophic tonsils, and recurrently inflamed tonsils. J. Med. Pharm. Chem. Res. 5, 987\u2013999 (2023).","journal-title":"J. Med. Pharm. Chem. Res."},{"key":"5683_CR82","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/cells10081900","volume":"10","author":"DWL Wong","year":"2021","unstructured":"Wong, D. W. L. et al. Multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients. Cells 10, 1900 (2021).","journal-title":"Cells"},{"key":"5683_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/spectrum.01347-23","volume":"11","author":"TM Lima","year":"2023","unstructured":"Lima, T. M. et al. Tonsils are major sites of persistence of SARS-CoV-2 in children. Microbiol. Spectr. 11, 1\u201314 (2023).","journal-title":"Microbiol. Spectr."},{"key":"5683_CR84","doi-asserted-by":"publisher","first-page":"7914","DOI":"10.3390\/ijms22157914","volume":"22","author":"SY Cheon","year":"2021","unstructured":"Cheon, S. Y. & Koo, B. N. Inflammatory response in COVID-19 patients resulting from the interaction of the inflammasome and SARS-CoV-2. Int. J. Mol. Sci. 22, 7914 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"5683_CR85","doi-asserted-by":"crossref","unstructured":"Khan, S. et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway. Elife 10, (2021).","DOI":"10.7554\/eLife.68563"},{"key":"5683_CR86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/tropicalmed9010013","volume":"9","author":"AA Al-Qahtani","year":"2024","unstructured":"Al-Qahtani, A. A., Alhamlan, F. S. & Al-Qahtani, A. A. Pro-Inflammatory and Anti-Inflammatory interleukins in infectious diseases: A comprehensive review. Trop. Med. Infect. Dis. 9, 13 (2024).","journal-title":"Trop. Med. Infect. Dis."},{"key":"5683_CR87","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00217-024-04522-y","volume":"250","author":"Z Can","year":"2024","unstructured":"Can, Z., Birinci, C., Kara, Y., Eserta\u015f, \u00dc. Z. \u00dc. & Kolayl\u0131, S. Determination of phenolic content and bioactive characterization of Anatolian propolis. Eur. Food Res. Technol. 250, 2059\u20132068 (2024).","journal-title":"Eur. Food Res. Technol."},{"key":"5683_CR88","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3201\/eid2606.200516","volume":"26","author":"J Harcourt","year":"2020","unstructured":"Harcourt, J. et al. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, united States. Emerg. Infect. Dis. 26, 1266\u20131273 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"5683_CR89","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3201\/eid2608.201246","volume":"26","author":"X Lu","year":"2020","unstructured":"Lu, X. et al. US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 26, 1654\u20131665 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"5683_CR90","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. Journal of hygiene. Am. J. Hygiene. 27, 493\u2013497 (1938).","journal-title":"Am. J. Hygiene"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05683-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:09:31Z","timestamp":1751396971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05683-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5683"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05683-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21627"}}